References

  1. Boulton AJ, Armstrong DG, Albert SF.  American Diabetes Association.  American Association of Clinical Endocrinologists Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care.  2008;31:1679-1685.
  2. Davis WA, Norman PE, Bruce DG, et al.  Predictors, consequences and costs of diabetes-related lower extremity amputations complicating type 2 diabetes: the Freemantle Diabetes Study.  Diabetologia.  2006;49:2634-2641.
  3. O'Brien JA, Patrick AR, Caro JJ.  Cost of managing complications resulting from type 2 diabetes mellitus in Canada.  BMC Health Serv Res.  2003;3:7.
  4. autEmbil JM, Bowering K.  “Foot Care”.  Can J Diabetes.  2013;37(suppl 145):S145-S149.
  5. Palumbo PJ, Melton LJ III. Peripheral vascular disease and diabetes. In: Diabetes in America: Diabetes Data. Government Printing Office, Washington. 1985. Available from: https://archive.org/stream/diabetesinameric00nati/diabetesinameric00nati_djvu.txt.
  6. Armstrong DG, Holtz-Neiderer K, Wendel C, et al. Skin temperature monitoring reduces the risk for diabetic foot ulceration in high-risk patients. Am J Med. 2007;120(12):1042–1046.
  7. Botros M, Kuhnke J, Embil J, et al.Best Practice Recommendations for the Prevention and Management of Diabetic Foot Ulcers.Available from:https://www.woundscanada.ca/docman/public/health-care-professional/bpr-workshop/560-bpr-prevention-and-management-of-diabetic-foot-ulcers/file
  8. Kuhnke JL, Botros M, Elliot J, et al.The case for diabetic foot screening.Wound Care Canada.2013;1(2):1-7.

Help us learn about our visitors!

Would you like to tell us a bit about yourself?

Yes No Maybe Later